IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 184 filers reported holding IMPAX LABORATORIES INC in Q2 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,891,000 | -26.8% | 79,785 | +5.4% | 0.01% | -30.0% |
| Q2 2016 | $2,585,000 | -29.2% | 75,685 | -32.2% | 0.01% | -37.5% |
| Q1 2016 | $3,652,000 | -21.7% | 111,700 | +2.4% | 0.02% | -20.0% |
| Q4 2015 | $4,665,000 | +28.1% | 109,100 | +5.5% | 0.02% | +25.0% |
| Q3 2015 | $3,641,000 | -33.3% | 103,400 | -8.2% | 0.02% | -27.3% |
| Q2 2015 | $5,457,000 | +1148.7% | 112,600 | +715.9% | 0.02% | +1000.0% |
| Q4 2014 | $437,000 | +33.6% | 13,800 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $327,000 | -94.9% | 13,800 | -93.5% | 0.00% | -93.3% |
| Q2 2014 | $6,364,000 | +45.2% | 212,200 | +27.9% | 0.03% | +36.4% |
| Q1 2014 | $4,383,000 | +9.2% | 165,900 | +3.9% | 0.02% | +4.8% |
| Q4 2013 | $4,012,000 | -17.9% | 159,600 | -33.0% | 0.02% | -22.2% |
| Q3 2013 | $4,886,000 | -31.8% | 238,200 | -33.6% | 0.03% | -34.1% |
| Q2 2013 | $7,162,000 | – | 359,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |